menu
    • menu

    Company profile for Polpharma Biologics

    NEW Drugs in Dev: 6
    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Polpharma Biologics is a leading biotechnology company specializing in developing and manufacturing biosimilar and novel biologic medicines. With state-of-the-art facilities in Poland and the Netherlands, we focus on delivering high-quality, accessible therapies to improve patient lives. Established as an independent entity in 2019, we leverage decades of pharmaceutical expertise and partner with global biopharma leaders to in...
    Polpharma Biologics is a leading biotechnology company specializing in developing and manufacturing biosimilar and novel biologic medicines. With state-of-the-art facilities in Poland and the Netherlands, we focus on delivering high-quality, accessible therapies to improve patient lives. Established as an independent entity in 2019, we leverage decades of pharmaceutical expertise and partner with global biopharma leaders to innovate and expand our portfolio. At Polpharma Biologics, we are driven by a commitment to excellence, innovation, and patient care.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Polpharma BiologicsPoland Flag
    Country
    Country
    Poland
    Address
    Address
    Gdansk Science & Technology Park Trzy Lipy 3, Building A 80-172 Gdansk
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://polpharmabiologics.com/en/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Polpharma, Tuteur Sign Biosimilar Licensing Deal for Autoimmune
    Polpharma, Tuteur Sign Biosimilar Licensing Deal for Autoimmune

    22 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260521106271/en/Polpharma-Biologics-and-Tuteur-Sign-Licensing-Agreement-for-a-Biosimilar-for-Autoimmune-Diseases

    BUSINESSWIRE
    22 May 2026
    Share Share
    Polpharma Bio And Libbs Pharma Ink Biosimilar Licensing Deal
    Polpharma Bio And Libbs Pharma Ink Biosimilar Licensing Deal

    10 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-10/polpharma-biologics-and-libbs-farmacêutica-sign-licensing-agreement-for-a-biosimilar-for-autoimmune

    PHARMIWEB
    10 Dec 2025
    Share Share
    Polpharma Bio Launches Tyruko for Biosimilar MS in U.S
    Polpharma Bio Launches Tyruko for Biosimilar MS in U.S

    17 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251116413366/en/Polpharma-Biologics-Confirms-U.S.-Launch-of-Tyruko-natalizumab-the-First-and-Only-Biosimilar-for-Multiple-Sclerosis

    BUSINESSWIRE
    17 Nov 2025
    Share Share
    Polpharma Bio Launches Europe's 1St Pre-Filled Syringe
    Polpharma Bio Launches Europe's 1St Pre-Filled Syringe

    21 Oct 2025

    // PRESS RELEASE

    https://polpharmabiologics.com/en/presentation-of-a-ranibizumab-biosimilar/

    PRESS RELEASE
    21 Oct 2025
    Share Share
    Polpharma, MS Pharma Ink Licensing Agreements for Biosimilars
    Polpharma, MS Pharma Ink Licensing Agreements for Biosimilars

    02 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250902492755/en/Polpharma-Biologics-and-MS-Pharma-Sign-Licensing-Agreements-for-Proposed-Vedolizumab-PB016-Ocrelizumab-PB018-and-Guselkumab-PB019-Biosimilars

    BUSINESSWIRE
    02 Sep 2025
    Share Share
    Polpharma Bio and Fresenius Sign Licensing Agreement fo PB016
    Polpharma Bio and Fresenius Sign Licensing Agreement fo PB016

    13 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250805925297/en/Polpharma-Biologics-and-Fresenius-Kabi-Sign-Licensing-Agreement-for-Proposed-Vedolizumab-Biosimilar-PB016

    BUSINESSWIRE
    13 Aug 2025
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search